Latest Breaking News On - Global phase - Page 2 : comparemela.com

Guardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications

Guardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Meldola
Emilia-romagna
Italy
Germany
Peter-fasching
Dino-amadori
Helmy-eltoukhy
Nicola-normanno
Nasdaq
Facebook
Breast-cancer-center
D-product-service

Guardant Health, Inc.: Guardant Health Receives EU IVDR Certification for Guardant360 CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications

Blood-based test for comprehensive genomic profiling of solid cancers meets requirements under stricter EU In Vitro Diagnostic Regulation IVDR certification from TÜV SÜD enables broader adoption

Meldola
Emilia-romagna
Italy
Germany
Michael-weist
Nicola-normanno
Zarak-khurshid
Dino-amadori
Helmy-eltoukhy
Peter-fasching
Gynecological-cancer-center
Nasdaq

Atea Pharmaceuticals Reports First Quarter 2024 Financial Results And Provides Business Update

Atea Pharmaceuticals Reports First Quarter 2024 Financial Results And Provides Business Update
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Boston
Massachusetts
United-states
Jean-pierre-sommadossi
Nasdaq
European-society-of-clinical-microbiology-infectious-diseases
Atea-pharmaceuticals-inc
Development-expenses
Program-for-second-generation-protease-inhibitors
Drug-administration
Atea-or-company
Full-enrollment-achieved

JCR Pharmaceuticals : FY2023 Second Half Results Briefing Session Script （2,257KB）

JCR Pharmaceuticals : FY2023 Second Half Results Briefing Session Script （2,257KB）
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Tokio
Tokyo
Japan
Brazil
United-states
Mizuho
Hokkaido
America
Brazilian
Japanese
Hiroyuki-sonoda
Ryo-mizuno

Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress

Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Beirut
Beyrouth
Lebanon
Spain
Cambridge
Cambridgeshire
United-kingdom
Boston
Massachusetts
United-states
Canada
Rio-de-janeiro